SA
ABBV icon

SpiderRock Advisors’s AbbVie ABBV Stock Holding History

SpiderRock Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$58.2M Buy
294,518
+47,954
+19% +$8.95M 0.93% 18
2024
Q2 		$42.3M Sell
246,564
-2,882
-1% -$477K 0.85% 20
2024
Q1 		$44.5M Buy
+249,446
New +$43M 1.11% 13
2017
Q1 		– Hold
0
– – – 169

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SpiderRock Advisors's ABBV Position: Q3 2024 in Review

SpiderRock Advisors increased its AbbVie (ABBV) stake by 19% in Q3 2024, buying an estimated $8.95M and bringing the position to 294,518 shares worth $58.2M. The position accounts for 0.93% of the portfolio, ranked #18.

SpiderRock Advisors first reported a position in ABBV in Q1 2024 and has held it in 3 quarters since. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • SpiderRock Advisors held 294,518 shares of AbbVie worth $58.2M as of Q3 2024.
  • SpiderRock Advisors bought 47,954 AbbVie shares in Q3 2024, an estimated $8.95M.
  • AbbVie made up 0.93% of SpiderRock Advisors's portfolio in Q3 2024, its #18 holding.
  • SpiderRock Advisors first reported a position in AbbVie in Q1 2024 and has held it in 3 quarters since.
  • 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.